Jef D. Boeke

Jef D. Boeke

Auto-generated profile, based on publicly available information

Jef D. Boeke

Institute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, USA

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2002 in Nature
Verified
Journal Article
Open access
PDF file
GGGuri Giaever
Guri Giaever
ACAngela M. Chu
Angela M. Chu
LNLi Ni
Li Ni
CCCarla Connelly
Carla Connelly
LRLinda Riles
Linda Riles
MJMark Johnston
Mark Johnston
Determining the effect of gene deletion is a fundamental approach to understanding gene function. Conventional genetic screens exhibit biases, and genes contributing to a phenotype are often missed. We systematically constructed a nearly complete collection of gene-deletion mutants (96% of annotated open reading frames, or ORFs) of the yeast Saccharomyces cerevisiae. DNA sequences dubbed ‘molecular bar codes’ uniquely identify each strain, enabling their growth to be analysed in parallel and the fitness contribution of each gene to be quantitatively assessed by hybridization to high-density oligonucleotide arrays. We show that previously known and new genes are necessary for optimal growth under six well-studied conditions: high salt, sorbitol, galactose, pH 8, minimal medium and nystatin treatment. Less than 7% of genes that exhibit a significant increase in messenger RNA expression are also required for optimal growth in four of the tested conditions. Our results validate the yeast gene-deletion collection as a valuable resource for functional genomics.

20 December 1991 in Science
Verified
Journal Article
Closed access
PDF file
SMStephen L. Mathias
Stephen L. Mathias
ASAlan F. Scott
Alan F. Scott
HKHaig H. Kazazian
Haig H. Kazazian
JBJef D. Boeke
Jef D. Boeke
AGAbram Gabriel
Abram Gabriel
L1 elements are highly repeated mammalian DNA sequences whose structure suggests dispersal by retrotransposition. A consensus L1 element encodes a protein with sequence similarity to known reverse transcriptases. The second open reading frame from the human L1 element L1.2A was expressed as a fusion protein targeted to Ty1 virus-like particles in Saccharomyces cerevisiae and shown to have reverse transcriptase activity. This activity was eliminated by a missense mutation in the highly conserved amino acid motif Y/F-X-D-D. Thus, L1 represents a potential source of the reverse transcriptase activity necessary for dispersion of the many classes of mammalian retroelements.

1 June 2006 in Annual Review of Biochemistry
Verified
Journal Article
Closed access
ASAnthony A. Sauve
Anthony A. Sauve
CWCynthia Wolberger
Cynthia Wolberger
VSVern L. Schramm
Vern L. Schramm
JBJef D. Boeke
Jef D. Boeke
Sirtuins are a family of NAD+-dependent protein deacetylases widely distributed in all phyla of life. Accumulating evidence indicates that sirtuins are important regulators of organism life span. In yeast, these unique enzymes regulate gene silencing by histone deacetylation and via formation of the novel compound 2′-O-acetyl-ADP-ribose. In multicellular organisms, sirtuins deacetylate histones and transcription factors that regulate stress, metabolism, and survival pathways. The chemical mechanism of sirtuins provides novel opportunities for signaling and metabolic regulation of protein deacetylation. The biological, chemical, and structural characteristics of these unusual enzymes are discussed in this review.

6 June 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JSJeffrey S. Smith
Jeffrey S. Smith
CBCarrie Baker Brachmann
Carrie Baker Brachmann
ICIvana Celic
Ivana Celic
MKMargaret A. Kenna
Margaret A. Kenna
SMShabazz Muhammad
Shabazz Muhammad
JBJef D. Boeke
Jef D. Boeke
The yeast Sir2 protein, required for transcriptional silencing, has an NAD + -dependent histone deacetylase (HDA) activity. Yeast extracts contain a NAD + -dependent HDA activity that is eliminated in a yeast strain from which SIR2 and its four homologs have been deleted. This HDA activity is also displayed by purified yeast Sir2p and homologous Archaeal, eubacterial, and human proteins, and depends completely on NAD + in all species tested. The yeast NPT1 gene, encoding an important NAD + synthesis enzyme, is required for rDNA and telomeric silencing and contributes to silencing of the HM loci. Null mutants in this gene have significantly reduced intracellular NAD + concentrations and have phenotypes similar to sir2 null mutants. Surprisingly, yeast from which all five SIR2 homologs have been deleted have relatively normal bulk histone acetylation levels. The evolutionary conservation of this regulated activity suggests that the Sir2 protein family represents a set of effector proteins in an evolutionarily conserved signal transduction pathway that monitors cellular energy and redox states.

1 May 2012 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
ZXZhongyu Xie
Zhongyu Xie
JDJunbiao Dai
Junbiao Dai
LDLunzhi Dai
Lunzhi Dai
MTMinjia Tan
Minjia Tan
ZCZhongyi Cheng
Zhongyi Cheng
YZYingming Zhao
Yingming Zhao
Histone protein post-translational modifications (PTMs) are significant for gene expression and DNA repair. Here we report the identification and validation of a new type of PTM in histones, lysine succinylation. The identified lysine succinylated histone peptides were verified by MS/MS of synthetic peptides, HPLC co-elution, and isotopic labeling. We identified 13, 7, 10, and 7 histone lysine succinylation sites in HeLa, mouse embryonic fibroblast, Drosophila S2, and Saccharomyces cerevisiae cells, respectively. We demonstrated that this histone PTM is present in all eukaryotic cells we examined. Mutagenesis of succinylation sites followed by functional assays implied that histone lysine succinylation can cause unique functional consequences. We also identified one and two histone lysine malonylation sites in HeLa and S. cerevisiae cells, respectively. Our results therefore increase potential combinatorial diversity of histone PTMs and suggest possible new connections between histone biology and metabolism.

10 March 2017 in Science
Verified
Journal Article
Closed access
PDF file
SRSarah M. Richardson
Sarah M. Richardson
LMLeslie A. Mitchell
Leslie A. Mitchell
GSGiovanni Stracquadanio
Giovanni Stracquadanio
KYKun Yang
Kun Yang
JDJessica S. Dymond
Jessica S. Dymond
JBJoel S. Bader
Joel S. Bader
We describe complete design of a synthetic eukaryotic genome, Sc2.0, a highly modified Saccharomyces cerevisiae genome reduced in size by nearly 8%, with 1.1 megabases of the synthetic genome deleted, inserted, or altered. Sc2.0 chromosome design was implemented with BioStudio, an open-source framework developed for eukaryotic genome design, which coordinates design modifications from nucleotide to genome scales and enforces version control to systematically track edits. To achieve complete Sc2.0 genome synthesis, individual synthetic chromosomes built by Sc2.0 Consortium teams around the world will be consolidated into a single strain by “endoreduplication intercross.” Chemically synthesized genomes like Sc2.0 are fully customizable and allow experimentalists to ask otherwise intractable questions about chromosome structure, function, and evolution with a bottom-up design strategy.